By NIAID ãæ·ç (ããã³ãã)ãã¯æ¯è¼çææé »åº¦ãé«ãæ§ç ã§ãèªç¶æ²»çãããã¨ããªããæ¾ç½®ããã°ç·æ§ã¯ç²¾å·£ä¸ä½çã女æ§ã¯è ¹èçãå¼ãèµ·ãããªã©é篤åããå±éºããããã¨ãç¥ããã¦ãã¾ããä¸çä¸ã§æ¯å¹´7800ä¸äººãææããæãä¸è¬çãªæ§ææçã§ããæ·ç ã«ã¤ãã¦ãç¾å¨ã®å»çç¾å ´ã§ããç¨ãããã2種é¡ã®æçç©è³ªã«æµææ§ãæã¤èãä¸å½å½å ã§å¢ãã¦ãããã¨ã確èªããã¾ããã Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016 http://journals.plos.org/plosmedicine/article?id=10.1371/jour

{{#tags}}- {{label}}
{{/tags}}